CXCR4 and chondrosarcoma: CXCR4 blockade can inhibit the effects of hypoxia on MMP1 expression and chondrosarcoma invasion in vitro, suggesting that CXCR4 blockade could be a therapeutic target to inhibit chondrosarcoma invasion and metastasis.